Tags

Type your tag names separated by a space and hit enter

Practical recommendations for gynecologic surgery during the COVID-19 pandemic.
Int J Gynaecol Obstet. 2020 Aug; 150(2):146-150.IJ

Abstract

Surgery in suspected/confirmed COVID-19 patients is a high-risk venture. In infected patients, COVID-19 is present in the body cavity. During surgery it could be nebulized in the spray generated by surgical instruments and could theoretically infect members of the surgical team. Nevertheless, some surgical gynecologic pathologies cannot be postponed. We present a list of the most frequent gynecologic diseases and recommendations on their surgical management during the COVID-19 pandemic, based on expert opinion, current available information, and international scientific society recommendations to support the work of gynecologists worldwide. In brief, any kind of surgical treatment should be scrutinized and postponed if possible. Nonoperative conservative treatment including pharmacological therapies for hormone-sensitive pathologies should be implemented. Health risk assessment by patient history and COVID-19 test before elective surgery are pivotal to protect both patients and healthcare providers. In confirmed COVID-19 patients or highly suspected cases, elective surgery should be postponed until full recovery.

Authors+Show Affiliations

Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32471012

Citation

Chiofalo, Benito, et al. "Practical Recommendations for Gynecologic Surgery During the COVID-19 Pandemic." International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, vol. 150, no. 2, 2020, pp. 146-150.
Chiofalo B, Baiocco E, Mancini E, et al. Practical recommendations for gynecologic surgery during the COVID-19 pandemic. Int J Gynaecol Obstet. 2020;150(2):146-150.
Chiofalo, B., Baiocco, E., Mancini, E., Vocaturo, G., Cutillo, G., Vincenzoni, C., Bruni, S., Bruno, V., Mancari, R., & Vizza, E. (2020). Practical recommendations for gynecologic surgery during the COVID-19 pandemic. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, 150(2), 146-150. https://doi.org/10.1002/ijgo.13248
Chiofalo B, et al. Practical Recommendations for Gynecologic Surgery During the COVID-19 Pandemic. Int J Gynaecol Obstet. 2020;150(2):146-150. PubMed PMID: 32471012.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Practical recommendations for gynecologic surgery during the COVID-19 pandemic. AU - Chiofalo,Benito, AU - Baiocco,Ermelinda, AU - Mancini,Emanuela, AU - Vocaturo,Giuseppe, AU - Cutillo,Giuseppe, AU - Vincenzoni,Cristina, AU - Bruni,Simone, AU - Bruno,Valentina, AU - Mancari,Rosanna, AU - Vizza,Enrico, Y1 - 2020/06/16/ PY - 2020/05/06/received PY - 2020/05/13/revised PY - 2020/05/25/accepted PY - 2020/5/30/pubmed PY - 2020/7/21/medline PY - 2020/5/30/entrez KW - COVID-19 KW - Cervical cancer KW - Coronavirus KW - Endometrial cancer KW - Endometriosis KW - Gynecology KW - Laparoscopy KW - Myoma KW - Ovarian cancer KW - Surgery KW - Urogynecology KW - Vulvar cancer SP - 146 EP - 150 JF - International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics JO - Int J Gynaecol Obstet VL - 150 IS - 2 N2 - Surgery in suspected/confirmed COVID-19 patients is a high-risk venture. In infected patients, COVID-19 is present in the body cavity. During surgery it could be nebulized in the spray generated by surgical instruments and could theoretically infect members of the surgical team. Nevertheless, some surgical gynecologic pathologies cannot be postponed. We present a list of the most frequent gynecologic diseases and recommendations on their surgical management during the COVID-19 pandemic, based on expert opinion, current available information, and international scientific society recommendations to support the work of gynecologists worldwide. In brief, any kind of surgical treatment should be scrutinized and postponed if possible. Nonoperative conservative treatment including pharmacological therapies for hormone-sensitive pathologies should be implemented. Health risk assessment by patient history and COVID-19 test before elective surgery are pivotal to protect both patients and healthcare providers. In confirmed COVID-19 patients or highly suspected cases, elective surgery should be postponed until full recovery. SN - 1879-3479 UR - https://www.unboundmedicine.com/medline/citation/32471012/Practical_recommendations_for_gynecologic_surgery_during_the_COVID-19_pandemic L2 - https://doi.org/10.1002/ijgo.13248 DB - PRIME DP - Unbound Medicine ER -